Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will be participating virtually in the following investor conferences.

• 11^th Annual SVB Leerink Global Healthcare Conference
  
  Fireside Chat on Wednesday, February 16 ^th at 9:00 a.m. Pacific Time / 12:00 p.m. Eastern Time

• Citi 2022 Healthcare Conference
  
  Fireside Chat on Thursday, February 24 ^th at 11:45 a.m. Pacific Time / 2:45 p.m. Eastern Time

• Cowen 42^nd Annual Health Care Conference
  
  Fireside Chat on Tuesday, March 8 ^th at 10:30 a.m. Pacific Time / 1:30 p.m. Eastern Time

Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.guardanthealth.com.

About Guardant Health

Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary tests, vast data sets and advanced analytics. The Guardant Health oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. Guardant Health has commercially launched Guardant360®, Guardant360 CDx, Guardant360 TissueNext™, Guardant360 Response™, and GuardantOMNI® tests for advanced stage cancer patients, and Guardant Reveal™ for early-stage cancer patients. These tests fuel development of its screening program, which aims to address the needs of asymptomatic individuals eligible for cancer screening.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220207005083/en/